Publication

Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study.

Journal Paper/Review - Jul 20, 2024

Rubbert-Roth Andrea, Kato Koji, Haraoui Boulos, Rischmueller Maureen, Liu Yanxi, Khan Nasser, Camp Heidi S, Xavier Ricardo M